Association of a CYP4A11 polymorphism and hypertension in the Mongolian and Han populations of China

Genetics and Molecular Research

Volumn 13, Issue 1, 2014, Pages 508-517

  Liang, J Q ^a,b   Yan, M R ^b   Yang, L ^b   Suyila, Q ^b   Cui, H W ^b   Su, X L ^a,b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b INNER MONGOLIA MEDICAL UNIVERSITY   (China)

Author keywords

CYP4A11; Han Chinese; Hypertension; Mongolians

Indexed keywords

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; GENETIC ASSOCIATION STUDIES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MONGOLIA; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SEX FACTORS;

EID: 84893976654     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2014.January.21.20     Document Type: Article

References (22)

1. Andersen G, Wegner L, Jensen DP, Glumer C, et al. (2005). PGC-1alpha Gly482Ser polymorphism associates with hypertension among Danish whites. Hypertension 45: 565-570.
2. Basson J, Simino J and Rao DC (2012). Between candidate genes and whole genomes: time for alternative approaches in blood pressure genetics. Curr. Hypertens. Rep. 14: 46-61.
3. Bellamine A, Wang Y, Waterman MR, Gainer JV, III, et al. (2003). Characterization of the CYP4A11 gene, a second CYP4A gene in humans. Arch. Biochem. Biophys. 409: 221-227.
4. Cardenas L, Renault N, Farce A, Cauffiez C, et al. (2011). Genetic polymorphism of CYP4A11 and CYP4A22 genes and in silico insights from comparative 3D modelling in a French population. Gene 487: 10-20.
5. Ehret GB (2010). Genome-wide association studies: contribution of genomics to understanding blood pressure and essential hypertension. Curr. Hypertens. Rep. 12: 17-25.
6. Fu Z, Nakayama T, Sato N, Izumi Y, et al. (2008a). A haplotype of the CYP4A11 gene associated with essential hypertension in Japanese men. J. Hypertens. 26: 453-461.
7. Fu Z, Nakayama T, Sato N, Izumi Y, et al. (2008b). Haplotype-based case study of human CYP4A11 gene and cerebral infarction in Japanese subject. Endocrine 33: 215-222.
8. Fu Z, Nakayama T, Sato N, Izumi Y, et al. (2012). Haplotype-based case-control study of CYP4A11 gene and myocardial infarction. Hereditas 149: 91-98.
9. Fu Z, Ma Y, Xie X, Huang D, et al. (2013a). A novel polymorphism of the CYP4A11 gene is associated with coronary artery disease. Clin. Appl. Thromb. Hemost. 19: 60-65.
10. Fu Z, Yang H, Ma Y, Huang D, et al. (2013b). Haplotype study of the CYP4A11 gene and coronary artery disease in Han and Uygur populations in China. Gene 512: 510-516.
11. Gainer JV, Bellamine A, Dawson EP, Womble KE, et al. (2005). Functional variant of CYP4A11 20-hydroxyeicosatetraenoic acid synthase is associated with essential hypertension. Circulation 111: 63-69.
12. Gainer JV, Lipkowitz MS, Yu C, Waterman MR, et al. (2008). Association of a CYP4A11 variant and blood pressure in black men. J. Am. Soc. Nephrol. 19: 1606-1612.
13. Hermann M, Hellermann JP, Quitzau K, Hoffmann MM, et al. (2009). CYP4A11 polymorphism correlates with coronary endothelial dysfunction in patients with coronary artery disease-the ENCORE Trials. Atherosclerosis 207: 476-479.
14. Holla VR, Adas F, Imig JD, Zhao X, et al. (2001). Alterations in the regulation of androgen-sensitive Cyp 4a monooxygenases cause hypertension. Proc. Natl. Acad. Sci. U. S. A. 98: 5211-5216.
15. Imaoka S, Ogawa H, Kimura S and Gonzalez FJ (1993). Complete cDNA sequence and cDNA-directed expression of CYP4A11, a fatty acid omega-hydroxylase expressed in human kidney. DNA Cell Biol. 12: 893-899.
16. Laffer CL, Gainer JV, Waterman MR, Capdevila JH, et al. (2008). The T8590C polymorphism of CYP4A11 and 20-hydroxyeicosatetraenoic acid in essential hypertension. Hypertension 51: 767-772.
17. Lasker JM, Chen WB, Wolf I, Bloswick BP, et al. (2000). Formation of 20-hydroxyeicosatetraenoic acid, a vasoactive and natriuretic eicosanoid, in human kidney. Role of Cyp4F2 and Cyp4A11. J. Biol. Chem. 275: 4118-4126.
18. Mayer B, Lieb W, Gotz A, Konig IR, et al. (2005). Association of the T8590C polymorphism of CYP4A11 with hypertension in the MONICA Augsburg echocardiographic substudy. Hypertension 46: 766-771.
19. Mayer B, Lieb W, Gotz A, Konig IR, et al. (2006). Association of a functional polymorphism in the CYP4A11 gene with systolic blood pressure in survivors of myocardial infarction. J. Hypertens. 24: 1965-1970.
20. Nakagawa K, Holla VR, Wei Y, Wang WH, et al. (2006). Salt-sensitive hypertension is associated with dysfunctional Cyp4a10 gene and kidney epithelial sodium channel. J. Clin. Invest. 116: 1696-1702.
21. Williams JS, Hopkins PN, Jeunemaitre X and Brown NJ (2011). CYP4A11 T8590C polymorphism, salt-sensitive hypertension, and renal blood flow. J. Hypertens. 29: 1913-1918.
22. Zou AP, Fleming JT, Falck JR, Jacobs ER, et al. (1996). 20-HETE is an endogenous inhibitor of the large-conductance Ca(2+)-activated K+ channel in renal arterioles. Am. J. Physiol. 270: R228-R237